Enteric Disease Testing Market Size & Analysis Report by End Use, By Technology and By Region – Global Opportunities & Forecast 2021-2028
Enteric Disease Testing Market Size & Analysis Report by End Use (Water and Food), By Technology (Traditional, Rapid, Convenience-based, Polymerase chain reaction, Immunoassay, Chromatography & spectrometry), and By Region
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global Enteric Disease Testing Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global Enteric Disease Testing Market Revenue Forecast till 2028
5. Global Enteric Disease Testing Market by End Use Revenue Forecast till 2028
5.1. Water
5.2. Food
6. Global Enteric Disease Testing Market by Technology Revenue Forecast till 2028
6.1. Traditional
6.2. Rapid
6.3. Convenience-based
6.4. Polymerase chain reaction
6.5. Immunoassay
6.6. Chromatography & spectrometry
7. Global Enteric Disease Testing Market by Region Forecast till 2028
7.1. North America Enteric Disease Testing Market Revenue Forecast till 2028
(Option 1: As a part of the free 25% customization)
7.1.1. North America Enteric Disease Testing Market by End Use
7.1.1.1. Water
7.1.1.2. Food
7.1.2. North America Enteric Disease Testing Market by Technology
7.1.2.1. Traditional
7.1.2.2. Rapid
7.1.2.3. Convenience-based
7.1.2.4. Polymerase chain reaction
7.1.2.5. Immunoassay
7.1.2.6. Chromatography & spectrometry
7.1.3. US Enteric Disease Testing Market All-Up
7.1.4. Canada Enteric Disease Testing Market All-Up
7.2. Europe Enteric Disease Testing Market Revenue Forecast till 2028
(Option 2: As a part of the free 25% customization)
7.2.1. Europe Enteric Disease Testing Market by End Use
7.2.1.1. Water
7.2.1.2. Food
7.2.2. Europe Enteric Disease Testing Market by Technology
7.2.2.1. Traditional
7.2.2.2. Rapid
7.2.2.3. Convenience-based
7.2.2.4. Polymerase chain reaction
7.2.2.5. Immunoassay
7.2.2.6. Chromatography & spectrometry
7.2.3. UK Enteric Disease Testing Market All-Up
7.2.4. Germany Enteric Disease Testing Market All-Up
7.2.5. France Enteric Disease Testing Market All-Up
7.2.6. Spain Enteric Disease Testing Market All-Up
7.2.7. Rest of Europe Enteric Disease Testing Market All-Up
7.3. Asia-Pacific Enteric Disease Testing Market Revenue Forecast till 2028
(Option 3: As a part of the free 25% customization)
7.3.1. Asia-Pacific Enteric Disease Testing Market by End Use
7.3.1.1. Water
7.3.1.2. Food
7.3.2. Asia-Pacific Enteric Disease Testing Market by Technology
7.3.2.1. Traditional
7.3.2.2. Rapid
7.3.2.3. Convenience-based
7.3.2.4. Polymerase chain reaction
7.3.2.5. Immunoassay
7.3.2.6. Chromatography & spectrometry
7.3.3. China Enteric Disease Testing Market All-Up
7.3.4. India Enteric Disease Testing Market All-Up
7.3.5. Japan Enteric Disease Testing Market All-Up
7.3.6. Rest of APAC Enteric Disease Testing Market All-Up
7.4. RoW Enteric Disease Testing Market Revenue Forecast till 2028
(Option 4: As a part of the free 25% customization)
7.4.1. RoW Enteric Disease Testing Market by End Use
7.4.1.1. Water
7.4.1.2. Food
7.4.2. RoW Enteric Disease Testing Market by Technology
7.4.2.1. Traditional
7.4.2.2. Rapid
7.4.2.3. Convenience-based
7.4.2.4. Polymerase chain reaction (PCR)
7.4.2.5. Immunoassay
7.4.2.6. Chromatography & spectrometry
7.4.3. Brazil Enteric Disease Testing Market All-Up
7.4.4. South Africa Enteric Disease Testing Market All-Up
7.4.5. Saudi Arabia Enteric Disease Testing Market All-Up
7.4.6. UAE Enteric Disease Testing Market All-Up
7.4.7. Rest of world (remaining countries of the LAMEA region) Enteric Disease Testing Market All-Up
8. Competitive Landscape Analysis
8.1. Porter’s Five Forces Analysis
8.2. Industry – Competitive Landscape
8.3. Market Presence (Intensity Mapping)
8.4. Key Strategic Market Developments
9. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
9.1. Cepheid.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Footprint & Employee Strength
9.1.4. Product Offerings
9.1.5. Financials
9.1.6. Key Company Developments
9.2. BD.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Footprint & Employee Strength
9.2.4. Product Offerings
9.2.5. Financials
9.2.6. Key Company Developments
9.3. Biomerica, Inc.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Footprint & Employee Strength
9.3.4. Product Offerings
9.3.5. Financials
9.3.6. Key Company Developments
9.4. Pro Lab Diagnostics Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Footprint & Employee Strength
9.4.4. Product Offerings
9.4.5. Financials
9.4.6. Key Company Developments
9.5. Techlab, Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Footprint & Employee Strength
9.5.4. Product Offerings
9.5.5. Financials
9.5.6. Key Company Developments
9.6. Coris BioConcept
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Footprint & Employee Strength
9.6.4. Product Offerings
9.6.5. Financials
9.6.6. Key Company Developments
9.7. Quest Diagnostics Incorporated.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Footprint & Employee Strength
9.7.4. Product Offerings
9.7.5. Financials
9.7.6. Key Company Developments
9.8. DiaSorin S.p.A.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Footprint & Employee Strength
9.8.4. Product Offerings
9.8.5. Financials
9.8.6. Key Company Developments
9.9. Trinity Biotech plc
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Footprint & Employee Strength
9.9.4. Product Offerings
9.9.5. Financials
9.9.6. Key Company Developments
9.10. BioMérieux SA
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Footprint & Employee Strength
9.10.4. Product Offerings
9.10.5. Financials
9.10.6. Key Company Developments
10. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
*The list of companies is based on preliminary research in this report, the companies in the final report may change based on research findings.
- Published Date: Nov -2020
- Report Format: Excel/PPT
- Report Code: UP2753-001001
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Enteric Disease Testing Market Size & Analysis Report by End Use, By Technology and By Region – Global Opportunities & Forecast 2021-2028
$ 4,499.00 – $ 6,649.00